← Eichor
Study identifier: NCT04917601 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

Condition: Childhood Obesity · Adolescent Obesity · mHealth  ·  Sponsor: Karolinska Institutet

PhaseNA
Planned participants680
Who can joinAll sexes, 4 Years to 17 Years
Healthy volunteersNo

About this study

Evira is a digital support system newly developed for treatment of childhood obesity. Through daily weighings at home using a special scale together with a message function in the Evira application, enabling fast and easy communication with the clinic, parents and the clinicians can easily follow the child's weight development. The purpose of this randomized controlled study is to evaluate the effect of adding Evira to the already locally used life-style treatment of childhood obesity.

This description comes directly from the study's public registry record.

Talk to the study team

Pernilla Danielsson Liljeqvist, Associate Professor  ·  +46 708 377734  ·  pernilla.danielsson-liljeqvist@regionstockholm.se

Always discuss trial participation with your own doctor first.

Locations (5)

University of MessinaMessina, ItalyNot Yet Recruiting
University of Campania Luigi VanvitelliNaples, ItalyRecruiting
St. Olavs HospitalTrondheim, NorwayActive Not Recruiting
Samodzielny Publiczny Szpital KlinicznySzczecin, PolandRecruiting
Kalmar barnklinikKalmar, SwedenCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04917601